Sana Biotechnology Inc (SANA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -217,690 | -157,766 | -107,475 | -283,255 | -195,138 |
| Depreciation Amortization | 11,698 | 7,641 | 3,746 | 17,543 | 13,293 |
| Accounts payable and accrued liabilities | -904 | -397 | -1,064 | 1,027 | 2,363 |
| Other Working Capital | -5,456 | -5,112 | -7,461 | 18,611 | 8,367 |
| Other Operating Activity | 36,360 | 31,461 | 46,622 | -7,508 | -30,508 |
| Operating Cash Flow | $-175,992 | $-124,173 | $-65,632 | $-253,582 | $-201,623 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -32,994 | -28,901 | -15,845 | -20,032 | -5,986 |
| Purchase Of Investment | -212,988 | -177,018 | -114,393 | -157,744 | -131,617 |
| Sale Of Investment | 216,347 | 134,509 | 53,010 | 349,788 | 294,305 |
| Investing Cash Flow | $-29,635 | $-71,410 | $-77,228 | $172,012 | $156,702 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 7,800 | 7,628 | N/A | N/A | N/A |
| Common Stock Issued | 191,306 | 189,396 | 186,397 | 31,646 | 29,928 |
| Financing Cash Flow | $199,106 | $197,024 | $186,397 | $31,646 | $29,928 |
| Beginning Cash Position | 137,349 | 137,349 | 137,349 | 187,273 | 187,273 |
| End Cash Position | 130,828 | 138,790 | 180,886 | 137,349 | 172,280 |
| Net Cash Flow | $-6,521 | $1,441 | $43,537 | $-49,924 | $-14,993 |
| Free Cash Flow | |||||
| Operating Cash Flow | -175,992 | -124,173 | -65,632 | -253,582 | -201,623 |
| Capital Expenditure | -32,994 | -28,901 | -15,845 | -20,032 | -5,986 |
| Free Cash Flow | -208,986 | -153,074 | -81,477 | -273,614 | -207,609 |